Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last ¥3,350 JPY
Change Today +35.00 / 1.06%
Volume 6.6K
As of 2:00 AM 09/2/15 All times are local (Market data is delayed by at least 15 minutes).

biofermin pharmaceutical co (4517) Snapshot

Open
¥3,300
Previous Close
¥3,315
Day High
¥3,385
Day Low
¥3,300
52 Week High
08/19/15 - ¥3,550
52 Week Low
10/16/14 - ¥2,650
Market Cap
40.7B
Average Volume 10 Days
15.1K
EPS TTM
¥181.29
Shares Outstanding
12.2M
EX-Date
09/28/15
P/E TM
18.5x
Dividend
¥60.00
Dividend Yield
1.79%
Current Stock Chart for BIOFERMIN PHARMACEUTICAL CO (4517)

Related News

No related news articles were found.

biofermin pharmaceutical co (4517) Related Businessweek News

No Related Businessweek News Found

biofermin pharmaceutical co (4517) Details

Biofermin Pharmaceutical Co., Ltd. manufactures and sells pharmaceutical products in Japan. It offers various anti diarrheal, laxative, and stomachic drug tablets. The company was founded in 1917 and is headquartered in Kobe, Japan.

170 Employees
Last Reported Date: 06/24/15
Founded in 1917

biofermin pharmaceutical co (4517) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

biofermin pharmaceutical co (4517) Key Developments

Biofermin Pharmaceutical Co., Ltd. to Report Q1, 2016 Results on Jul 27, 2015

Biofermin Pharmaceutical Co., Ltd. announced that they will report Q1, 2016 results on Jul 27, 2015

Biofermin Pharmaceutical Co., Ltd., Annual General Meeting, Jun 24, 2015

Biofermin Pharmaceutical Co., Ltd., Annual General Meeting, Jun 24, 2015.

Biofermin Pharmaceutical Co., Ltd. to Report Fiscal Year 2015 Results on May 11, 2015

Biofermin Pharmaceutical Co., Ltd. announced that they will report fiscal year 2015 results on May 11, 2015

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
4517:JP ¥3,350.00 JPY +35.00

4517 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 4517.
View Industry Companies
 

Industry Analysis

4517

Industry Average

Valuation 4517 Industry Range
Price/Earnings 18.6x
Price/Sales 3.8x
Price/Book 1.7x
Price/Cash Flow 18.8x
TEV/Sales 2.9x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BIOFERMIN PHARMACEUTICAL CO, please visit www.biofermin.co.jp. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.